Inferra AI / Company / DLB
Dolby Laboratories, Inc.
DLB · Financials
Last earnings Jul 30, 2026
Key results
Total revenuequarter
$316 million
Third Quarter Fiscal 2025 Financial Highlights Total revenue was $316 million, compared to $289 million for the third quarter of fiscal 2024.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
GAAP net incomefull-year
$46 million
GAAP net income was $46 million or $0.48 per diluted share, compared to GAAP net income of $38 million or $0.40 per diluted share for the third quarter of fiscal 2024.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Net incomefull-year
$76 million
On a non-GAAP basis, third quarter net income was $76 million or $0.78 per diluted share, compared to $69 million or $0.71 per diluted share for the third quarter of fiscal 2024.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Non-GAAP net incomequarter
$ 46,071
$ 46,071 $ 38,444 Stock-based compensation (1) 30,728 29,337 Amortization of acquisition-related intangibles (2) 10,016 3,101 Restructuring charges/(credits) (547 ) 4,078 Income tax adjustments (10,606 ) (6,210 ) Non-GAAP net income attributable to Dolby Laboratories, Inc.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Revenuequarter
$315,546 thousand
Total revenue 315,546 288,818 1,042,106 968,915
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Gross marginquarter
$271,544 thousand
Gross profit 271,544 253,155 921,493 862,415
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Research and developmentquarter
$65,982 thousand
Research and development 65,982 65,501 194,327 195,027
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Operating expensesquarter
$223,905 thousand
Total operating expenses 223,905 216,372 686,211 650,443
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Operating incomequarter
$47,639 thousand
Operating income 47,639 36,783 235,282 211,972
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Net incomequarter
$46,071 thousand
Net income attributable to Dolby Laboratories, Inc. $ 46,071 $ 38,444 $ 205,686 $ 203,255
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
AI analysis
Q3 2025 · reported Jul 31, 2025
Based on: Earnings release + parent 8-K — transcript not held
Headline figures
| Metric | Q3 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Total revenue | $316 million | — | — |
| Non-GAAP net income | $ 46,071 | — | — |
| Revenue | $315,546 thousand | — | — |
| Gross margin | $271,544 thousand | — | — |
| Research and development | $65,982 thousand | — | — |
| Operating expenses | $223,905 thousand | — | — |
| Operating income | $47,639 thousand | — | — |
| Net income | $46,071 thousand | — | — |
Guidance · company-stated
No guidance located in the held release
“Effective tax rate is anticipated to be around 23%”
Margin
Capital allocation
Dolby repurchased approximately 526,000 shares of its common stock for approximately $40 million, and ended the quarter with approximately $312 million of stock repurchase authorization available going forward.
Event summary
Dolby Laboratories Reports Third Quarter 2025 Financial Results
Based on: Earnings release + parent 8-K — transcript not held
Guidance & outlook
No guidance located in the held release
Capital allocation
Dolby repurchased approximately 526,000 shares of its common stock for approximately $40 million, and ended the quarter with approximately $312 million of stock repurchase authorization available going forward.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Dividend Today, Dolby announced a cash dividend of $0.33 per share of Class A and Class B common stock, payable on August 20, 2025, to stockholders of record as of the close of business on August 12, 2025.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Strategy & priorities
Non-GAAP Financial Information To supplement Dolby s financial statements presented on a GAAP basis, Dolby management uses, and Dolby provides to investors, certain non-GAAP financial measures as an additional tool to evaluate Dolby s operating results in a manner that focuses on what Dolby s management believes to be its ongoing business operations and performance.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Risks & headwinds
Financial Outlook Dolby s financial outlook relies, in part, on estimates of royalty-based revenue that take into consideration various factors that are subject to uncertainty, including consumer demand for electronic products.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
In addition, actual results could differ materially from the estimates Dolby is providing below due in part to uncertainty resulting from the macroeconomic effect of certain conditions, including developments concerning trade restrictions and changes in trade or diplomatic relationships, supply chain constraints, international conflicts, geopolitical instability, and fluctuations in inflation and interest rates.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
The uncertainty resulting from these factors has greatly reduced visibility into Dolby s future outlook.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
These assumptions are subject to risks and uncertainties.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Forward-Looking Statements Certain statements in this press release and in our earnings calls, including, but not limited to, expected financial results for the fourth quarter of fiscal 2025 and full year fiscal 2025, Dolby s ability to expand existing business, navigate challenging periods, pursue its long-term growth opportunities, and advance its other long-term objectives are forward-looking statements that inherently involve substantial risks and uncertainties.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
These forward-looking statements are based on management s current expectations, and as a result of certain risks and uncertainties, actual results may differ materially from those provided.
SEC original ↗Dolby Laboratories, Inc. — Earnings release (8-K exhibit)EX-99Jul 31, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
30 documents- Q2 2026
- 8-KDLB
Aug 27, 2026
- 10-QDLB
Jul 30, 2026
- 8-KDLB
Jul 30, 2026
- Q1 2026
- 10-QDLB
Apr 30, 2026
- 8-KDLB
Apr 30, 2026
- Q4 2025
- 8-KDLB
- 10-QDLB
Jan 29, 2026
- 8-KDLB
Jan 29, 2026
- Q3 2025
- 10-KDLB
Nov 18, 2025
- 8-KDLB
Nov 18, 2025
- 8-KDLB
Nov 14, 2025
- Q2 2025
- 10-QDLB
Jul 31, 2025
- 8-KDLB
Jul 31, 2025
- Q1 2025
- 10-QDLB
- 8-KDLB
- Q4 2024
- 8-KDLB
- 10-QDLB
Jan 30, 2025
- 8-KDLB
Jan 29, 2025
- Q3 2024
- 10-KDLB
Nov 19, 2024
- 8-KDLB
Nov 19, 2024
- 8-KDLB
Nov 15, 2024
- Q2 2024
- 8-KDLB
Aug 19, 2024
- 10-QDLB
- 8-KDLB
- Q1 2024
- 8-KDLB
- 10-QDLB
- 8-KDLB
- Q4 2023
- 8-KDLB
- 10-QDLB
- 8-KDLB
Earnings releases
12 documentsPresentations
0 documentsNo presentations for Dolby Laboratories, Inc. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Dolby Laboratories, Inc. are held in this edition of the library.
Mentioned by
1 companyOther tracked companies whose held documents mention Dolby Laboratories, Inc. by name or ticker. A mention is counted once per document, from the document text the library holds.
“ers of $12.6B, +28% • Total revenue (GAAP) of $9.8B, +6%; adjusted revenue*… …business to Dolby Laboratories, recording a pre-tax gain on sale of $341 million. • Performed an interim impairment test at our Colibrium Additive reporting unit given decl”
See also the earnings calendar for every tracked company’s next earnings date.